Tag Archives: longevity research

Longevity Preparedness: A New Metric for a Longer-Living Population

Longevity Preparedness: A New Metric for a Longer-Living Population

Longevity is no longer a theoretical concept. It has become a reality, one that is reshaping healthcare systems, financial planning, and societal expectations. But longevity alone does not guarantee preparedness for the years that it adds. So, the question becomes: how ready are we, really?

As global life expectancy continues to rise, we are slowly learning that other systems are not necessarily keeping pace with this shift. Factors such as finances, health status, housing, care planning, and behavioral readiness are not advancing at the same rate as lifespan extension. Instead, they seem to be fragmented and underdeveloped.

Continue reading →

Market Report: A Look at Longevity in 2026

Longevity and anti-senescence therapy — medical and scientific approaches designed to extend human lifespan and promote healthy aging by targeting the biological processes that cause aging, cellular damage, and decline in bodily functions — are having more than a moment right now. The industry is on an upward swing, ready to expand from nearly $800 billion to an expected $1,868.2 billion by 2034. That’s a projected compound annual growth rate of approximately 8.2%, driven by products, services, and technologies designed to reverse senescence, the process where cells lose the ability to divide and function properly, and mitigate aging and age-related diseases.

The benefits of the longevity industry are twofold: it provides opportunities to investors and health care practitioners while enhancing and expanding health and quality of life for patients. Let’s take a look at what the market has to say.

Continue reading →

GPT-4b Enters The Laboratory: OpenAI’s New Model Takes On Longevity Science


Over the past year, OpenAI has dominated headlines with ChatGPT and breakthroughs in generative AI. Now, the company has quietly entered the laboratory, and its first biological research initiative signals a profound shift in longevity science.

In collaboration with Retro Biosciences, OpenAI has developed GPT-4b micro, a specialized AI model that surpasses human capabilities in stem cell research. This venture into biological engineering marks a decisive step beyond language processing, and the results are remarkable. Early testing shows that the model achieves cellular reprogramming with 50 times greater efficiency than conventional methods, rewriting established rules of cellular biology.

Continue reading →